Collision brain tumor with atypical meningioma and glioblastoma: Case report

[1]  Xiaowei Qin,et al.  Clear Cell Meningioma in the Central Nervous System: Analysis of Surveillance, Epidemiology, and End Results Database , 2021, Frontiers in Oncology.

[2]  P. Bradley,et al.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines. , 2020, International journal of surgery.

[3]  B. Bendok,et al.  A Rare Intracranial Collision Tumor of Meningioma and Metastatic Uterine Adenocarcinoma: Case Report and Literature Review. , 2020, World neurosurgery.

[4]  G. Barnett,et al.  Clear cell meningioma: A clinicopathologic study of a rare meningioma subtype in 35 patients. , 2020, World neurosurgery.

[5]  L. Moral,et al.  An Unusual Intracranial Collision Tumor of Anaplastic Ependymoma and Atypical Meningioma , 2019, American Journal of Clinical Pathology.

[6]  V. T. Truong,et al.  Collision Occurrence of Meningioma and Astrocytoma: A Case Report and Literature Review , 2019, Asian journal of neurosurgery.

[7]  S. Toms,et al.  A Comparative Report on Intracranial Tumor-to-Tumor Metastasis and Collision Tumors. , 2018, World neurosurgery.

[8]  M. Davis.  Glioblastoma: Overview of Disease and Treatment. , 2016, Clinical journal of oncology nursing.

[9]  Shaoshan Li,et al.  Astrocytoma simultaneously present with Meningioma-a report of two cases and review of the literature , 2016, Chinese Neurosurgical Journal.

[10]  Yun-Bao Guo,et al.  An intraventricular meningioma and recurrent astrocytoma collision tumor: a case report and literature review , 2015, World Journal of Surgical Oncology.

[11]  P. Kleihues,et al.  The Definition of Primary and Secondary Glioblastoma , 2012, Clinical Cancer Research.

[12]  Kouhei Yamamoto,et al.  Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature , 2010, Journal of Neuro-Oncology.

[13]  B. Tuğcu,et al.  Two distinct primary brain tumors, in same region of the same patient: a case report , 2006, Journal of Neuro-Oncology.

[14]  C. Heldin,et al.  B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.